Author details

Full Name

Andrew T Hattersley

Affiliation

ORCID

Career Start Year

1985

Papers

762

H Index

133

Expertise

CM4AI Collaborator

PMID	Paper Title	Journal Title	Published Year
36600150	FOXP3 TSDR Measurement Could Assist Variant Classification and Diagnosis of IPEX Syndrome.		2023
36109160	Recurrent 17q12 microduplications contribute to renal disease but not diabetes.	Journal of Medical Genetics	2023
36368478	Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches.	Journal of Clinical Epidemiology	2023
36355183	The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes.	Diabetologia	2023
36411396	The impact of population-level HbA screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.	Diabetologia	2023
37604891	Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits.	Nat Commun	2023
37604891	Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits.	Nat Commun	2023
37602910	Incretin hormone responses to carbohydrate and protein/fat are preserved in adults with sulfonylurea-treated KCNJ11 neonatal diabetes.		2023
37756263	Waist circumference and glycaemia are strong predictors of progression to diabetes in individuals with prediabetes in sub-Saharan Africa: 4-year prospective cohort study in Malawi.		2023
37740543	TSH and FT4 reference interval recommendations and prevalence of gestational thyroid dysfunction: quantification of current diagnostic approaches.		2023
37653058	Bringing precision medicine to the management of pregnancy in women with glucokinase-MODY: a study of diagnostic accuracy and feasibility of non-invasive prenatal testing.		2023
37988592	Penetrance and expressivity of mitochondrial variants in a large clinically unselected population.		2023
37798380	Genome-wide association study of placental weight identifies distinct and shared genetic influences between placental and fetal growth.	Nat Genet	2023
37794253	Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine.	Nat Med	2023
37639628	The Role of ONECUT1 Variants in Monogenic and Type 2 Diabetes Mellitus.		2023
37878891	Association of gestational free and total triiodothyronine with gestational hypertension, preeclampsia, preterm birth and birth weight: an individual-participant data meta-analysis.		2023
37473454	Laboratory Guidelines Are Needed for Diagnostic Genetic Testing for Monogenic Diabetes.		2023
37214872	Systematic Review of Treatment of Beta-Cell Monogenic Diabetes.		2023
37212888	Correction to: The impact of population-level HbA screening on reducing diabetes diagnostic delay in middle-aged adults: a UK Biobank analysis.		2023
37090505	Type 2 Diabetes risk alleles in Peptidyl-glycine Alpha-amidating Monooxygenase influence GLP-1 levels and response to GLP-1 Receptor Agonists.		2023
37272950	HbA screening for the diagnosis of diabetes. Reply to BroÅ¾ J, Brabec M, KrollovÃ¡ P et al [letter].		2023
37398003	Whole genome analysis of plasma fibrinogen reveals population-differentiated genetic regulators with putative liver roles.	medRxiv	2023
36704923	Infancy-onset diabetes caused by de-regulated AMPylation of the human endoplasmic reticulum chaperone BiP.	EMBO Mol Med	2023
37328784	Comparison of causal forest and regression-based approaches to evaluate treatment effect heterogeneity: an application for type 2 diabetes precision medicine.	BMC Med Inform Decis Mak	2023
37130959	Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.	Nat Biotechnol	2023
37130959	Author Correction: Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models.	Nat Biotechnol	2023
37012456	Genetic effects on the timing of parturition and links to fetal birth weight.	Nat Genet	2023
36808723	Monogenic disease analysis establishes that fetal insulin accounts for half of human fetal growth.		2023
36477733	Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study.		2023
36477734	Patient preference for second- and third-line therapies in type 2 diabetes: a prespecified secondary endpoint of the TriMaster study.		2023
37316353	Corrigendum to 'Identifying type 1 and 2 diabetes in research datasets where classification biomarkers are unavailable: assessing the accuracy of published approaches' [Journal of Clinical Epidemiology (2023) 34-44].		2023
35138411	Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes.	Diabetologia	2022
36104811	Variants influencing age at diagnosis of HNF1A-MODY.	Molecular Medicine	2022
35590056	Mild MDPL in a patient with a novel de novo missense variant in the Cys-B region of POLD1.	European Journal of Human Genetics	2022
35450869	Continuous glucose monitoring demonstrates low risk of clinically significant hypoglycemia associated with sulphonylurea treatment in an African type 2 diabetes population: results from the OPTIMAL observational multicenter study.	BMJ Open Diabetes Research and Care	2022
35900879	Patient-led rapid titration of basal insulin in gestational diabetes is associated with improved glycaemic control and lower birthweight.	Diabetic Medicine	2022
36008798	Assessing whether genetic scores explain extra variation in birthweight, when added to clinical and anthropometric measures.	BMC Pediatrics	2022
35501400	Congenital beta cell defects are not associated with markers of islet autoimmunity, even in the context of high genetic risk for type 1 diabetes.	Diabetologia	2022
36205650	Routine Islet Autoantibody Testing in Clinically Diagnosed Adult-Onset Type 1 Diabetes Can Help Identify Misclassification and the Possibility of Successful Insulin Cessation.	Diabetes Care	2022
35604955	Islet autoantibody positivity in an adult population with recently diagnosed diabetes in Uganda.	PLoS ONE	2022
36257325	Reduced penetrance of MODY-associated HNF1A/HNF4A variants but not GCK variants in clinically unselected cohorts.	Am J Hum Genet	2022
35856135	A biallelic loss-of-function PDIA6 variant in a second patient with polycystic kidney disease, infancy-onset diabetes, and microcephaly.	Clinical Genetics	2022
36427949	Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study.	Lancet Digit Health	2022
35916147	Higher Arm Versus Lower Arm Systolic Blood Pressure and Cardiovascular Outcomes: a Meta-Analysis of Individual Participant Data From the INTERPRESS-IPD Collaboration.	Hypertension	2022
35596568	Association of Thyroid Peroxidase Antibodies and Thyroglobulin Antibodies with Thyroid Function in Pregnancy: An Individual Participant Data Meta-Analysis.	Thyroid	2022
35534565	Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes.	Nat Med	2022
36537518	ISPAD Clinical Practice Consensus Guidelines 2022: The diagnosis and management of monogenic diabetes in children and adolescents.		2022
35050370	Response to Comment on Meek et al. Reappearance of C-Peptide During the Third Trimester in Type 1 Diabetes Pregnancy: Pancreatic Regeneration or Fetal Hyperinsulinism? Diabetes Care 2021;44:1826-1834.	Diabetes Care	2022
34686905	Systematic genetic testing for recessively inherited monogenic diabetes: a cross-sectional study in paediatric diabetes clinics.	Diabetologia	2022
34789499	Syndromic Monogenic Diabetes Genes Should Be Tested in Patients With a Clinical Suspicion of Maturity-Onset Diabetes of the Young.	Diabetes	2022